Reduced therapeutic activity of warfarin during treatment with oral isotretinoin
Identifieur interne : 000E02 ( Istex/Checkpoint ); précédent : 000E01; suivant : 000E03Reduced therapeutic activity of warfarin during treatment with oral isotretinoin
Auteurs : P. Fiallo [Italie]Source :
- British Journal of Dermatology [ 0007-0963 ] ; 2004-01.
English descriptors
- Teeft :
- Abdominal pain, Acad, Acad dermatol, Acral osteolysis, Acral ulcerations, Adult patients, Angiosarcoma, Angiosarcoma patients, Anticoagulant therapy, Antinuclear antibodies, Arch dermatol, Atrophic plaques, Azathioprine, Basement membrane zone, Basilar region, Biopsy, Blastic, Blastic lymphoma, Blood serology, Bone densitometry, Bone marrow, British association, British journal, Brosing dermopathy, Brown macules, Bullous reaction, Calcinosis, Calcinosis cutis, Calculus, Canal carpien, Captopril, Carpal, Carpal tunnel syndrome, Case report, Cefpodoxime proxetil, Cellulitis, Centre, Clinical course, Clinical features, Clinical practice, Common cutaneous, Complement components, Complete remission, Contact dermatitis, Correspondence figure, Cutaneous, Cutis, Cytoplasmic expression, Daily number, Danazol, Danazol treatment, David geffen school, Deep skin necrosis, Dermal, Dermal dendrocytes, Dermal papillae, Dermatol, Dermatologist, Dermatology, Dermis, Dystrophic calcinosis cutis, Environmental temperature, Epidermal, Epidermal keratinocytes, Epidermal keratins, Epidermis, Eruption, Eruptive, Erythema, Erythema multiforme, Erythematosus, Erythematous, Exogenous oestrogens, Factor xiiia, Foam cells, Foamy cells, Forearm injury, Generalized eruptive histiocytoma, Generalized eruptive histiocytosis, Genital, Genital lesions, Genital mucosa, Granular cell layer, Growth factor, Haematodermic neoplasm, Haemorrhagic cystitis, Hair follicle, Hepatitis, Hereditary angioedema, Herpes, Herpes zoster, Histiocytosis, Hospital admission, Hydroxychloroquine, Hydroxychloroquine sulphate, Immunol lett, Important role, Infectious diseases, Inhibitor, Inner right thigh, Internal medicine, Isotretinoin, Italy references, Keratinizing differentiation, Keratinocytes, Kitasato university school, Labia majora, Lesion, Lesional biopsy, Lichen, Lichen planus, Lichen sclerosus, Lisinopril, Liver kidney, Localized scleroderma, Long history, Lower extremities, Lupus erythematosus, Lymphatic, Lymphatic vessels, Lymphocyte, Lymphoma, Malignant, Many tumours, Maximum temperature, Median, Median nerve, Median nerves, Medical dermatology, Molecular defect, Mucin deposits, Mucinosis, Neoplasm, Nephrogenic fibrosing dermopathy, Ngers, Nonparametric poisson regression model, Normal amount, Normal controls, Normal range, Normal values, Oral contraception, Oral isotretinoin, Oral pathol, Outermost surface, Overlap syndrome, Palo alto, Papillomatous surface, Papule, Pathol, Peculiar type, Pediatr dermatol, Pemphigus, Pemphigus erythematosus, Pemphigus vulgaris, Pilot study, Pinkish erythematous papules, Planus, Plaque, Plasmacytoid dendritic cells, Present case, Present study, Prominent areas, Prominent skin symptoms, Range years, Rare disease, Relapse, Relapse biopsies, Renal, Renal dialysis, Renal disease, Renal transplant, Residual keratinocytes, Respective time points, Reticular, Reticular erythematous mucinosis, Reticular erythematous mucinosis syndrome, Rheumatoid arthritis, Right hand, Right index, Right side, Right subauricular region, Sarcoma, Sclerosus, Seasonal factors, Sertraline, Serum levels, Serum protein levels, Severe form, Severe multicentric reticulohistiocytosis, Skin biopsy, Skin lesions, Skin necrosis, Small number, Squamous cell carcinoma, Steroid, Subcutaneous mass, Supraclavicular region, Surface irregularity, Surg pathol, Surgical, Surgical decompression, Surgical removal, Syndrome, Systemic, Systemic administration, Systemic antimalarials, Systemic sclerosis, Tacrolimus, Tacrolimus ointment, Temporal scalp, Therapeutic effect, Third case, Tissue damage, Topical tacrolimus, Trichilemmal, Trichilemmal cyst, Trichilemmal keratinization, Trichilemmal tumor, Trichilemmal tumour, Tumour, Tumour cells, Tumour expansion, Tumour stage, Ulceration, Urine, Urine analysis, Vaginal calculi, Various sizes, Verruciform, Verruciform xanthoma, Virus infection, Warfarin, World health organisation, Xanthoma, Xanthomatous cells.
Url:
DOI: 10.1111/j.1365-2133.2004.05737.x
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
ISTEX:5853BD8A553F88B14751566C4A0967124429D41BLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Reduced therapeutic activity of warfarin during treatment with oral isotretinoin</title>
<author><name sortKey="Fiallo, P" sort="Fiallo, P" uniqKey="Fiallo P" first="P." last="Fiallo">P. Fiallo</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:5853BD8A553F88B14751566C4A0967124429D41B</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1111/j.1365-2133.2004.05737.x</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-F38QTQWM-W/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000F22</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000F22</idno>
<idno type="wicri:Area/Istex/Curation">000F22</idno>
<idno type="wicri:Area/Istex/Checkpoint">000E02</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000E02</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Reduced therapeutic activity of warfarin during treatment with oral isotretinoin</title>
<author><name sortKey="Fiallo, P" sort="Fiallo, P" uniqKey="Fiallo P" first="P." last="Fiallo">P. Fiallo</name>
<affiliation wicri:level="1"><country wicri:rule="url">Italie</country>
<wicri:regionArea>Department of Health Sciences, Section of Social Dermatology, University of Genoa, Viale Benedetto XV, 7, I‐16132 Genoa</wicri:regionArea>
<wicri:noRegion>I‐16132 Genoa</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">British Journal of Dermatology</title>
<title level="j" type="alt">BRITISH JOURNAL OF DERMATOLOGY</title>
<idno type="ISSN">0007-0963</idno>
<idno type="eISSN">1365-2133</idno>
<imprint><biblScope unit="vol">150</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="164">164</biblScope>
<biblScope unit="page" to="164">164</biblScope>
<biblScope unit="page-count">1</biblScope>
<publisher>Blackwell Science Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2004-01">2004-01</date>
</imprint>
<idno type="ISSN">0007-0963</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0007-0963</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Abdominal pain</term>
<term>Acad</term>
<term>Acad dermatol</term>
<term>Acral osteolysis</term>
<term>Acral ulcerations</term>
<term>Adult patients</term>
<term>Angiosarcoma</term>
<term>Angiosarcoma patients</term>
<term>Anticoagulant therapy</term>
<term>Antinuclear antibodies</term>
<term>Arch dermatol</term>
<term>Atrophic plaques</term>
<term>Azathioprine</term>
<term>Basement membrane zone</term>
<term>Basilar region</term>
<term>Biopsy</term>
<term>Blastic</term>
<term>Blastic lymphoma</term>
<term>Blood serology</term>
<term>Bone densitometry</term>
<term>Bone marrow</term>
<term>British association</term>
<term>British journal</term>
<term>Brosing dermopathy</term>
<term>Brown macules</term>
<term>Bullous reaction</term>
<term>Calcinosis</term>
<term>Calcinosis cutis</term>
<term>Calculus</term>
<term>Canal carpien</term>
<term>Captopril</term>
<term>Carpal</term>
<term>Carpal tunnel syndrome</term>
<term>Case report</term>
<term>Cefpodoxime proxetil</term>
<term>Cellulitis</term>
<term>Centre</term>
<term>Clinical course</term>
<term>Clinical features</term>
<term>Clinical practice</term>
<term>Common cutaneous</term>
<term>Complement components</term>
<term>Complete remission</term>
<term>Contact dermatitis</term>
<term>Correspondence figure</term>
<term>Cutaneous</term>
<term>Cutis</term>
<term>Cytoplasmic expression</term>
<term>Daily number</term>
<term>Danazol</term>
<term>Danazol treatment</term>
<term>David geffen school</term>
<term>Deep skin necrosis</term>
<term>Dermal</term>
<term>Dermal dendrocytes</term>
<term>Dermal papillae</term>
<term>Dermatol</term>
<term>Dermatologist</term>
<term>Dermatology</term>
<term>Dermis</term>
<term>Dystrophic calcinosis cutis</term>
<term>Environmental temperature</term>
<term>Epidermal</term>
<term>Epidermal keratinocytes</term>
<term>Epidermal keratins</term>
<term>Epidermis</term>
<term>Eruption</term>
<term>Eruptive</term>
<term>Erythema</term>
<term>Erythema multiforme</term>
<term>Erythematosus</term>
<term>Erythematous</term>
<term>Exogenous oestrogens</term>
<term>Factor xiiia</term>
<term>Foam cells</term>
<term>Foamy cells</term>
<term>Forearm injury</term>
<term>Generalized eruptive histiocytoma</term>
<term>Generalized eruptive histiocytosis</term>
<term>Genital</term>
<term>Genital lesions</term>
<term>Genital mucosa</term>
<term>Granular cell layer</term>
<term>Growth factor</term>
<term>Haematodermic neoplasm</term>
<term>Haemorrhagic cystitis</term>
<term>Hair follicle</term>
<term>Hepatitis</term>
<term>Hereditary angioedema</term>
<term>Herpes</term>
<term>Herpes zoster</term>
<term>Histiocytosis</term>
<term>Hospital admission</term>
<term>Hydroxychloroquine</term>
<term>Hydroxychloroquine sulphate</term>
<term>Immunol lett</term>
<term>Important role</term>
<term>Infectious diseases</term>
<term>Inhibitor</term>
<term>Inner right thigh</term>
<term>Internal medicine</term>
<term>Isotretinoin</term>
<term>Italy references</term>
<term>Keratinizing differentiation</term>
<term>Keratinocytes</term>
<term>Kitasato university school</term>
<term>Labia majora</term>
<term>Lesion</term>
<term>Lesional biopsy</term>
<term>Lichen</term>
<term>Lichen planus</term>
<term>Lichen sclerosus</term>
<term>Lisinopril</term>
<term>Liver kidney</term>
<term>Localized scleroderma</term>
<term>Long history</term>
<term>Lower extremities</term>
<term>Lupus erythematosus</term>
<term>Lymphatic</term>
<term>Lymphatic vessels</term>
<term>Lymphocyte</term>
<term>Lymphoma</term>
<term>Malignant</term>
<term>Many tumours</term>
<term>Maximum temperature</term>
<term>Median</term>
<term>Median nerve</term>
<term>Median nerves</term>
<term>Medical dermatology</term>
<term>Molecular defect</term>
<term>Mucin deposits</term>
<term>Mucinosis</term>
<term>Neoplasm</term>
<term>Nephrogenic fibrosing dermopathy</term>
<term>Ngers</term>
<term>Nonparametric poisson regression model</term>
<term>Normal amount</term>
<term>Normal controls</term>
<term>Normal range</term>
<term>Normal values</term>
<term>Oral contraception</term>
<term>Oral isotretinoin</term>
<term>Oral pathol</term>
<term>Outermost surface</term>
<term>Overlap syndrome</term>
<term>Palo alto</term>
<term>Papillomatous surface</term>
<term>Papule</term>
<term>Pathol</term>
<term>Peculiar type</term>
<term>Pediatr dermatol</term>
<term>Pemphigus</term>
<term>Pemphigus erythematosus</term>
<term>Pemphigus vulgaris</term>
<term>Pilot study</term>
<term>Pinkish erythematous papules</term>
<term>Planus</term>
<term>Plaque</term>
<term>Plasmacytoid dendritic cells</term>
<term>Present case</term>
<term>Present study</term>
<term>Prominent areas</term>
<term>Prominent skin symptoms</term>
<term>Range years</term>
<term>Rare disease</term>
<term>Relapse</term>
<term>Relapse biopsies</term>
<term>Renal</term>
<term>Renal dialysis</term>
<term>Renal disease</term>
<term>Renal transplant</term>
<term>Residual keratinocytes</term>
<term>Respective time points</term>
<term>Reticular</term>
<term>Reticular erythematous mucinosis</term>
<term>Reticular erythematous mucinosis syndrome</term>
<term>Rheumatoid arthritis</term>
<term>Right hand</term>
<term>Right index</term>
<term>Right side</term>
<term>Right subauricular region</term>
<term>Sarcoma</term>
<term>Sclerosus</term>
<term>Seasonal factors</term>
<term>Sertraline</term>
<term>Serum levels</term>
<term>Serum protein levels</term>
<term>Severe form</term>
<term>Severe multicentric reticulohistiocytosis</term>
<term>Skin biopsy</term>
<term>Skin lesions</term>
<term>Skin necrosis</term>
<term>Small number</term>
<term>Squamous cell carcinoma</term>
<term>Steroid</term>
<term>Subcutaneous mass</term>
<term>Supraclavicular region</term>
<term>Surface irregularity</term>
<term>Surg pathol</term>
<term>Surgical</term>
<term>Surgical decompression</term>
<term>Surgical removal</term>
<term>Syndrome</term>
<term>Systemic</term>
<term>Systemic administration</term>
<term>Systemic antimalarials</term>
<term>Systemic sclerosis</term>
<term>Tacrolimus</term>
<term>Tacrolimus ointment</term>
<term>Temporal scalp</term>
<term>Therapeutic effect</term>
<term>Third case</term>
<term>Tissue damage</term>
<term>Topical tacrolimus</term>
<term>Trichilemmal</term>
<term>Trichilemmal cyst</term>
<term>Trichilemmal keratinization</term>
<term>Trichilemmal tumor</term>
<term>Trichilemmal tumour</term>
<term>Tumour</term>
<term>Tumour cells</term>
<term>Tumour expansion</term>
<term>Tumour stage</term>
<term>Ulceration</term>
<term>Urine</term>
<term>Urine analysis</term>
<term>Vaginal calculi</term>
<term>Various sizes</term>
<term>Verruciform</term>
<term>Verruciform xanthoma</term>
<term>Virus infection</term>
<term>Warfarin</term>
<term>World health organisation</term>
<term>Xanthoma</term>
<term>Xanthomatous cells</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>Italie</li>
</country>
</list>
<tree><country name="Italie"><noRegion><name sortKey="Fiallo, P" sort="Fiallo, P" uniqKey="Fiallo P" first="P." last="Fiallo">P. Fiallo</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E02 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd -nk 000E02 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Istex |étape= Checkpoint |type= RBID |clé= ISTEX:5853BD8A553F88B14751566C4A0967124429D41B |texte= Reduced therapeutic activity of warfarin during treatment with oral isotretinoin }}
This area was generated with Dilib version V0.6.33. |